
Single Cell Technology
Oct 25, 2023 · Single Cell Technology is a group of dedicated scientists and engineers who’ve spent the last decade figuring out how to eliminate the obstacles that have limited antibody discovery.
About Us - Single Cell Technology
Learn about Single Cell Technology, and how we went from a barcode scanner to our groundbreaking Abtheneum antibody discovery platform.
AbTherx Partners with Single Cell Technology for First Antibody ...
Mar 13, 2024 · About Single Cell Technology, Inc. Single Cell Technology is an antibody discovery R&D provider with a pioneering platform that can both accelerate the process and capture all available data.
SurfScreen Pilot for TIGIT - Single Cell Technology
Oct 25, 2023 · This project used a recombinant extracellular domain (ECD) of TIGIT to immunize the mice, and it is common that antibodies derived from that type of immunogen do not always bind to …
AbTherx, SCT and Vaccinex Announce Collaboration
Mountain View, Calif. – May 13, 2025 – AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a …
Single Cell @ AET 2025
Antibody Engineering & Therapeutics 2025 December 14-17, 2025 Marriott Marquis San Diego Antibodies in San Diego Single Cell Technology is headed to AET 2025. Stay tuned for more details …
Sorted cell populations from HSA-immunized mice lymphocytes were deposited onto several picowell devices. All secreted IgGs are captured on an antibody capture slide and assessed for antigen …
PEGS Boston 2025 - singlecelltechnology.com
Apr 22, 2025 · PEGS is the stage for Single Cell to roll out the red carpet and premier Case Study Cinemas, our new "studio" where we feature Abtheneum blockbuster achievements and features.
News - Single Cell Technology
Mar 13, 2024 · AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle Challenging Antibody Drug Targets 22 April 2025
Our Science - Single Cell Technology
Instead of having to literally pick just a handful of cells to work with early in the process – and leave huge amounts of data and possible pathways unexplored – it’s now possible to collect quality data from …